IJE Advance Access originally published online on October 22, 2006
International Journal of Epidemiology 2006 35(6):1412-1416; doi:10.1093/ije/dyl222
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Published by Oxford University Press on behalf of the International Epidemiological Association © The Author 2006; all rights reserved.
Cohort Profile |
Cohort profile: the Asia Pacific Cohort Studies Collaboration
1 The George Institute, University of Sydney, Australia.
2 Department of Epidemiology and Social Medicine, Xuanwu Hospital, Capital Medical University, China.
3 Department of Evidence Based Medicine, Fuwai Hospital & CVD Institute, Chinese Academy of Medical Science & Peking Union Medical College, China.
4 Department of Clinical Pharmacology and Therapeutics, Tohoku University, Japan.
5 Department of Community Medicine, The University of Hong Kong, Hong Kong.
6 Institute of Biomedical Sciences, Academia Sinica, Taiwan.
7 Clinical Trials Research Unit, University of Auckland, New Zealand.
8 Department of Preventive Medicine, Yonsei University College of Medicine, Korea.
9 Department of Epidemiology and Health Promotion, Graduate School of Public Health, Yonsei University, Korea.
10 Department of Health Science, Shiga University of Medical Science, Japan.
* Corresponding author. The George Institute, University of Sydney, Australia. E-mail: rhuxley@george.org.au
| The first 150 words of the full text of this article appear below. |
 |
How did the study come about? |
|---|
Although less well recognized than in the West, cardiovascular disease (CVD) is the leading cause of disease in Asia. This is despite known differences in the distribution of risk factors for CVD in Asia, compared with Europe and North America, such as lower average total cholesterol and body mass index (BMI). The nature of CVD also tends to be different in Asia, where there are more strokes than coronary heart disease (CHD) events, and strokes are more often haemorrhagic than ischaemic, compared with the West.
By 1999 the knowledge gap in Asia was a clear impediment to progress in treating and preventing CVD in the continent. Most of the existing studies from Asia were of small size or short duration and, thus, could not provide reliable information as to the way risk factors, well-researched in the West, act upon CVD in Asia. A notable exception was the Eastern Stroke and
|
What does it cover? |
|---|
|
Who is in the sample? |
|---|
|
How often have they been followed-up? |
|---|
|
What has been measured? |
|---|
Baseline
Repeat values
Outcomes
|
What has it found? Key findings and publications |
|---|
|
What are the main strengths and weaknesses? |
|---|
|
Can I get hold of the data? Where can I find out more? |
|---|
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. D. Batty, F. Barzi, M. Woodward, K. Jamrozik, J. Woo, H. C. Kim, H. Ueshima, R. R. Huxley, and for the Asia Pacific Cohort Studies Collaboration Adult height and cancer mortality in Asia: the Asia Pacific Cohort Studies Collaboration Ann. Onc., November 4, 2009; (2009) mdp363v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Nakamura, R Huxley, A Ansary-Moghaddam, and M Woodward The hazards and benefits associated with smoking and smoking cessation in Asia: a meta-analysis of prospective studies Tob. Control, October 1, 2009; 18(5): 345 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. O'Seaghdha, V. Perkovic, T. H. Lam, S. McGinn, F. Barzi, D. F. Gu, A. Cass, I. Suh, P. Muntner, G. G. Giles, et al. Blood Pressure Is a Major Risk Factor for Renal Death: An Analysis of 560 352 Participants From the Asia-Pacific Region Hypertension, September 1, 2009; 54(3): 509 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Y. Lee, F. Barzi, M. Woodward, G D. Batty, G. G Giles, J. W. Wong, K. Jamrozik, T. H. Lam, H. Ueshima, H. C. Kim, et al. Adult height and the risks of cardiovascular disease and major causes of death in the Asia-Pacific region: 21 000 deaths in 510 000 men and women Int. J. Epidemiol., August 1, 2009; 38(4): 1060 - 1071. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Nakamura, F Barzi, R Huxley, T-H Lam, I Suh, J Woo, H C Kim, V L Feigin, D Gu, M Woodward, et al. Does cigarette smoking exacerbate the effect of total cholesterol and high-density lipoprotein cholesterol on the risk of cardiovascular diseases? Heart, June 1, 2009; 95(11): 909 - 916. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Nakamura, F. Barzi, T.-H. Lam, R. Huxley, V. L. Feigin, H. Ueshima, J. Woo, D. Gu, T. Ohkubo, C. M.M. Lawes, et al. Cigarette Smoking, Systolic Blood Pressure, and Cardiovascular Diseases in the Asia-Pacific Region Stroke, June 1, 2008; 39(6): 1694 - 1702. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F Barzi, R Huxley, K Jamrozik, T-H Lam, H Ueshima, D Gu, H C Kim, and M Woodward Association of smoking and smoking cessation with major causes of mortality in the Asia Pacific Region: the Asia Pacific Cohort Studies Collaboration Tob. Control, June 1, 2008; 17(3): 166 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Perkovic, R. Huxley, Y. Wu, D. Prabhakaran, and S. MacMahon The Burden of Blood Pressure-Related Disease: A Neglected Priority for Global Health Hypertension, December 1, 2007; 50(6): 991 - 997. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Woodward, F. Barzi, V. Feigin, D. Gu, R. Huxley, K. Nakamura, A. Patel, S. Ho, K. Jamrozik, and for the Asia Pacific Cohort Studies Collaboration Associations between high-density lipoprotein cholesterol and both stroke and coronary heart disease in the Asia Pacific region Eur. Heart J., November 1, 2007; 28(21): 2653 - 2660. [Abstract] [Full Text] [PDF]
|
|